A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib.

Ulcerative colitis (UC) is an inflammatory bowel disease of autoimmune origin with an estimated prevalence in Spain of 0.39%. Current treatments for UC do not achieve high long-term efficacy.

Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding.

Objective: The aim of this study was to assess the efficacy and safety of intravenous ferric carboxymaltose (FCM) following hospitalization for acute gastrointestinal bleeding (AGIB) in the context of a restrictive transfusion strategy.

Patients And Methods: A retrospective single-center study analyzed patients with AGIB (excluding AGIB secondary to portal hypertension) administered a single FCM dose with or without blood transfusion.

Results: Eighty-six episodes in 84 patients were analyzed.